Τετάρτη 27 Ιουνίου 2018

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)

The therapeutic strategy for non-benign meningiomas is controversial. The objective of this study was to prospectively investigate the impact of high dose radiation therapy (RT) on the progression-free survival (PFS) rate at 3 years in WHO grade II and III meningioma patients.

https://ift.tt/2tAP7u5

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου